These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mercury in vaccines may not pose harm. Child Health Alert; 2003 Jan; 21():1. PubMed ID: 12608349 [No Abstract] [Full Text] [Related]
5. Mercury in infants given vaccines containing thiomersal. Halsey NA; Goldman LR Lancet; 2003 Feb; 361(9358):698-9; author reply 699. PubMed ID: 12606189 [No Abstract] [Full Text] [Related]
6. The evidence for the safety of thiomersal in newborn and infant vaccines. Clements CJ Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295 [TBL] [Abstract][Full Text] [Related]
7. The role of mercury in the pathogenesis of autism. Bernard S; Enayati A; Roger H; Binstock T; Redwood L Mol Psychiatry; 2002; 7 Suppl 2():S42-3. PubMed ID: 12142947 [No Abstract] [Full Text] [Related]
8. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Pichichero ME; Gentile A; Giglio N; Umido V; Clarkson T; Cernichiari E; Zareba G; Gotelli C; Gotelli M; Yan L; Treanor J Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396 [TBL] [Abstract][Full Text] [Related]
9. [Mercury in vaccines]. Hessel L Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581 [TBL] [Abstract][Full Text] [Related]
10. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines. Clements CJ; McIntyre PB Expert Opin Drug Saf; 2006 Jan; 5(1):17-29. PubMed ID: 16370953 [TBL] [Abstract][Full Text] [Related]
12. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants. Magos L J Appl Toxicol; 2003; 23(4):263-9. PubMed ID: 12884410 [TBL] [Abstract][Full Text] [Related]
13. Thiomersal in vaccines: is removal warranted? Clements CJ; Ball LK; Ball R; Pratt RD Drug Saf; 2001; 24(8):567-74. PubMed ID: 11480489 [TBL] [Abstract][Full Text] [Related]
14. Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease. Bigham M; Copes R Drug Saf; 2005; 28(2):89-101. PubMed ID: 15691220 [TBL] [Abstract][Full Text] [Related]
15. Comparison of organic and inorganic mercury distribution in suckling rat. Orct T; Blanusa M; Lazarus M; Varnai VM; Kostial K J Appl Toxicol; 2006; 26(6):536-9. PubMed ID: 17080402 [TBL] [Abstract][Full Text] [Related]
16. An assessment of thimerosal use in childhood vaccines. Ball LK; Ball R; Pratt RD Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700 [TBL] [Abstract][Full Text] [Related]
17. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. Stajich GV; Lopez GP; Harry SW; Sexson WR J Pediatr; 2000 May; 136(5):679-81. PubMed ID: 10802503 [TBL] [Abstract][Full Text] [Related]
18. Thiomersal-containing vaccines - a review of the current state of knowledge. Gołoś A; Lutyńska A Przegl Epidemiol; 2015; 69(1):59-64, 157-61. PubMed ID: 25862449 [TBL] [Abstract][Full Text] [Related]
19. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Parker SK; Schwartz B; Todd J; Pickering LK Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856 [TBL] [Abstract][Full Text] [Related]
20. Elimination of thimerosal from vaccines set as goal. Miller JL Am J Health Syst Pharm; 1999 Aug; 56(16):1589, 1593. PubMed ID: 10459378 [No Abstract] [Full Text] [Related] [Next] [New Search]